期刊文献+

子痫前期患者凝血指标的监测及其临床意义 被引量:7

The monitoring and significance in plasma coagulation of preeclampsia patients
下载PDF
导出
摘要 目的探讨子痫前期患者血浆凝血指标的变化及意义。方法采用非妊娠妇女组40例(对照组)、正常晚期妊娠组40例、子痫前期组40例进行血浆凝血指标的监测分析。结果子痫前期组与对照组比较,凝血酶原时间(PT)缩短、纤维蛋白原(Fib)增高、D-二聚体升高,差异有统计学意义(P<0.05);子痫前期组与正常晚期妊娠组比较,PT缩短,Fib、D-二聚体升高,差异有统计学意义(P<0.05)。结论子痫前期患者存在凝血功能异常与纤溶抑制功能亢进,提示监测发现凝血指标明显异常者,有利于指导高危妊娠临床诊断、早期干预,预防产后出血、DIC等分娩期并发症的发生。 To discuss the significance and changes in plasma coagulation of preeclampsia patients. Methods The plasma coagulation of 40 non -pregnant women (the control group), 40 normal late pregnancy and 40 preeclampsia was measured and analyzed. Results Preeclampsia group compared with control group, prothrombin time shortened, fibrinogen elevated and D - dimmer elevated (P 〈 0.05 ) ; preeclampsia group compare with normal late pregnancy, prothrombin time shortened, fibrinogen and D -dimmer elevated (P 〈 0.05). Conclusion There are coagulopathy and fibrinolysis hyperthyroidism in the preeclampsia patients which prompts detected significant abnormalities in coagulation and that is benefit to guide the clinical diagnosis of high - risk pregnancy, early intervention, prevention of postpartum hemorrhage, DIC and other intrapartum complications.
出处 《宁夏医学杂志》 CAS 2012年第3期236-237,共2页 Ningxia Medical Journal
关键词 子痫前期 血浆凝血酶原时间 活化部分凝血活酶时间 Preeclampsia Prothrombin time Activated partial thromboplastin time
  • 相关文献

参考文献3

二级参考文献1

共引文献173

同被引文献55

  • 1赵智慧(综述),柳志红(审校).血栓形成倾向与妊娠静脉血栓栓塞症的治疗[J].中国分子心脏病学杂志,2003,3(1):46-49. 被引量:7
  • 2GEORGE EM, GRANGER JP. Mechanisms and potential therapies for preeclampsia [ J ]. Curr Hypertens Rep,2011, 13(4) :269-275.
  • 3DUSSE LM,RIOS DR,PINHEIRO MB,et al. Pre- eclampsia : relationship between coagulation, fibrinolysis and inflam- mation [ J ]. Clin Chim Acta,2011,412 ( 1-2 ) : 17-21.
  • 4PINHEIRO MD, JUNQUEIRA DR, COELHO FF, et al. D-dimer in preeclampsia: Review and meta-analysis [ J ]. Clin Chim Acta,2012,in press.
  • 5ANDERSON UD, OLSSON MG, KRISTENSEN KH, et al. Review: Biochemical markers to predict preeclampsia [ J ]. Placenta,2012,33 (Suppl) :42-47.
  • 6BOIJ R, SVENSSON J, NILSSON-EKDAHL K, et al. Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia [ J ]. Am J Reprod Immunol 2012,68 (3) :258-270.
  • 7Dekker GA.l~isk f&ctor$ for preec]&mpsi&[J].Clin Obstet Oynecol 1999 42(5): 422-435.
  • 8熊钰.出凝血功能改变在子痫前期发病机制中的作用[D].复旦大学2008
  • 9George EM, Granger JP. Mechanisms and potential therapies for preeclampsia [ J ]. Curr Hypertens Rep, 2011,13(4) : 269 -275.
  • 10Dusse LM, Rios DR, Pinheiro MB, et al. Pre- eclampsia: relationship between coagulation, fibrinol- ysis and inflammation[J]. Clin Chim Acta, 2011,412 (1 -2) : 17 -21.

引证文献7

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部